Лифилейцел

Rec. INN (наименование, зарегистрированное ВОЗ)

USAN (наименование, принятое к употреблению в США)

DB17107

Прочие противоопухолевые препараты

N (не классифицировано FDA)

2306267-74-1

human culture expanded activated autologous T cells for cell-based immunotherapy. The cell substance is a heterogeneous mixture consisting of CD4+ and CD8+ tumor-infiltrating lymphocytes (TIL), derived from isolated metastatic tumor biopsy of patients with metastatic melanoma, and cultured in the presence of feeder cells (irradiated allogeneic mononuclear cells from healthy donors) and human recombinant interleukin 2 (IL-2)/OKT3 anti-CD3 antibody (muromonab-CD3 (59)(29)) for T-cell activation.

Поделиться этой страницей